Contribution of Rare and Low-Frequency Variants to Multiple Sclerosis Susceptibility in the Italian Continental Population
暂无分享,去创建一个
M. Filippi | V. Martinelli | G. Comi | F. Guerini | A. Gallo | F. Esposito | G. De Bellis | S. D'alfonso | M. Leone | C. Comi | E. Mangano | E. Virgilio | N. Barizzone | M. Sorosina | E. Mascia | F. Clarelli | S. Santoro | M. Zuccalà | F. Martinelli Boneschi | R. Bordoni | C. Basagni | Santosh Anand | Alessandro Pizzino | P D P A E A D C F S P R R G C F F M A L C F Crociani Vecchio Ragonese Gajofatto Scarpini Berto | F G M p M L B A A R G M. P B G A P F E D E P M L S G Esposito Liberatore Rodegher Rossi Radaelli Moi
[1] T. B. Hansen,et al. RNA-Seq profiling of leukocytes reveals a sex-dependent global circular RNA upregulation in multiple sclerosis and 6 candidate biomarkers. , 2020, Human molecular genetics.
[2] V. Martinelli,et al. Inferring Multiple Sclerosis Stages from the Blood Transcriptome via Machine Learning , 2020, Cell reports. Medicine.
[3] U. Muthane,et al. Novel and reported variants in Parkinson's disease genes confer high disease burden among Indians. , 2020, Parkinsonism & related disorders.
[4] Gerta Rücker,et al. How to perform a meta-analysis with R: a practical tutorial , 2019, Evidence-Based Mental Health.
[5] Simon C. Potter,et al. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility , 2019, Science.
[6] H. Ullum,et al. Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk , 2018, Cell.
[7] Anthony J. Payne,et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps , 2018, Nature Genetics.
[8] Timothy A. Miller,et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene in and for Therapeutic , 2018 .
[9] Hyojin Kim,et al. COEXPEDIA: exploring biomedical hypotheses via co-expressions associated with medical subject headings (MeSH) , 2016, Nucleic Acids Res..
[10] Allison Hainline,et al. A general approach for combining diverse rare variant association tests provides improved robustness across a wider range of genetic architectures , 2015, European Journal of Human Genetics.
[11] F. Alkuraya,et al. Exome-based case–control association study using extreme phenotype design reveals novel candidates with protective effect in diabetic retinopathy , 2015, Human Genetics.
[12] Tom R. Gaunt,et al. Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel , 2015, Nature Communications.
[13] M. Daly,et al. Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants , 2014, Nature.
[14] C. Schlötterer,et al. Sequencing pools of individuals — mining genome-wide polymorphism data without big funding , 2014, Nature Reviews Genetics.
[15] G. Abecasis,et al. Rare-variant association analysis: study designs and statistical tests. , 2014, American journal of human genetics.
[16] G. Zamora-López,et al. Transcriptomic Profile Reveals Gender-Specific Molecular Mechanisms Driving Multiple Sclerosis Progression , 2014, PloS one.
[17] J. Nielsen,et al. Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics. , 2014, Molecular & cellular proteomics : MCP.
[18] M. Pirinen,et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis , 2013, Nature Genetics.
[19] D. MacArthur,et al. Negligible impact of rare autoimmune-locus coding-region variants on missing heritability , 2013, Nature.
[20] Lei Sun,et al. Robust and Powerful Tests for Rare Variants Using Fisher's Method to Combine Evidence of Association From Two or More Complementary Tests , 2013, Genetic epidemiology.
[21] G. Abecasis,et al. Exome sequencing and complex disease: practical aspects of rare variant association studies , 2012, Human molecular genetics.
[22] Shane J. Neph,et al. Systematic Localization of Common Disease-Associated Variation in Regulatory DNA , 2012, Science.
[23] Iuliana Ionita-Laza,et al. Scan-statistic approach identifies clusters of rare disease variants in LRP2, a gene linked and associated with autism spectrum disorders, in three datasets. , 2012, American journal of human genetics.
[24] Adrian Liston,et al. The immunogenetic architecture of autoimmune disease. , 2012, Cold Spring Harbor perspectives in biology.
[25] Dan-Yu Lin,et al. A general framework for detecting disease associations with rare variants in sequencing studies. , 2011, American journal of human genetics.
[26] Kathryn Roeder,et al. Testing for an Unusual Distribution of Rare Variants , 2011, PLoS genetics.
[27] Vikas Bansal,et al. A statistical method for the detection of variants from next-generation resequencing of DNA pools , 2010, Bioinform..
[28] M. Brown,et al. The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. , 2010, Human molecular genetics.
[29] Jing Cui,et al. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score , 2009, The Lancet Neurology.
[30] Judy H. Cho,et al. Finding the missing heritability of complex diseases , 2009, Nature.
[31] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[32] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[33] S. Browning,et al. A Groupwise Association Test for Rare Mutations Using a Weighted Sum Statistic , 2009, PLoS genetics.
[34] M. Spitz,et al. Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. , 2008, American journal of human genetics.
[35] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[36] S. Hauser,et al. The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration , 2006, Neuron.
[37] Jonathan C. Cohen,et al. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. , 2006, The New England journal of medicine.